The new Duke study used a larger sample size and a wider cross-section of children with Attention Deficit Disorder compared to previous studies.
"We looked at three common markers associated with damaged chromosomes and did not find increased genetic abnormalities in children taking either medication, regardless of a variety of factors, such as age, sex, body weight, height, race, and ADHD subtype," said author Scott Kollins. Kollins was referring to methylphenidate and amphetamine, the active ingredient in Adderall.
About two million American children have Attention Deficit Hyperactivity Disorder.
This study appeared in the Journal of the American Academy of Child & Adolescent Psychiatry.
Labels: medications, side_effects, cancer
Posted By: Aspen Education Group 0 Comments







